Shuttle Pharmaceuticals Holdings, Inc. Profile Avatar - Palmy Investing

Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropi…

Drug Manufacturers - Specialty & Generic
US, Rockville [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of SHPH's Analysis
CIK: 1757499 CUSIP: 825693203 ISIN: US8256932034 LEI: - UEI: -
Secondary Listings
SHPH has no secondary listings inside our databases.